{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:32:11Z","timestamp":1777512731432,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07619-4","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:25:05Z","timestamp":1770395105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TCRcloud: a global visualization tool for T-cell and B-cell receptor transcripts"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6582-7365","authenticated-orcid":false,"given":"Eric","family":"de Sousa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-5259","authenticated-orcid":false,"given":"Joana R.","family":"L\u00e9rias","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6569-8647","authenticated-orcid":false,"given":"Carolina M.","family":"Gorgulho","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Chaves-Ferreira","sequence":"additional","affiliation":[]},{"given":"Vitaly","family":"Balan","sequence":"additional","affiliation":[]},{"given":"Wenjing","family":"Pan","sequence":"additional","affiliation":[]},{"given":"Miranda","family":"Byrne-Steele","sequence":"additional","affiliation":[]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Jian","family":"Han","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-6916","authenticated-orcid":false,"given":"Margarida","family":"Gama-Carvalho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-8077","authenticated-orcid":false,"given":"Markus","family":"Maeurer","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"7619_CR1","doi-asserted-by":"crossref","unstructured":"Roh W, Chen PL, Reuben A, Spencer CN, Prieto PA, Miller JP, Gopalakrishnan V, Wang F, Cooper ZA, Reddy SM, et al. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci Transl Med. 2017;9.","DOI":"10.1126\/scitranslmed.aah3560"},{"key":"7619_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.21037\/atm.2017.06.48","volume":"5","author":"KR Voong","year":"2017","unstructured":"Voong KR, Feliciano J, Becker D, Levy B. Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer. Ann Transl Med. 2017;5:376.","journal-title":"Ann Transl Med"},{"key":"7619_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00002371-200501000-00007","volume":"28","author":"JH Zhou","year":"2005","unstructured":"Zhou JH, Dudley ME, Rosenberg SA, Robbins PF. Persistence of multiple tumor-specific T-Cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother. 2005;28:53\u201362.","journal-title":"J Immunother"},{"key":"7619_CR4","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1158\/1078-0432.CCR-14-0433","volume":"20","author":"YC Lu","year":"2014","unstructured":"Lu YC, Yao X, Crystal JS, Li YF, El-Gamil M, Gross C, Davis L, Dudley ME, Yang JC, Samuels Y, et al. Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions. Clin Cancer Res. 2014;20:3401\u201310.","journal-title":"Clin Cancer Res"},{"key":"7619_CR5","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.4049\/jimmunol.172.10.6057","volume":"172","author":"J Huang","year":"2004","unstructured":"Huang J, El-Gamil M, Dudley ME, Li YF, Rosenberg SA, Robbins PF. T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product. J Immunol. 2004;172:6057\u201364.","journal-title":"J Immunol"},{"key":"7619_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nm.3161","volume":"19","author":"PF Robbins","year":"2013","unstructured":"Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E, et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med. 2013;19:747\u201352.","journal-title":"Nat Med"},{"key":"7619_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1158\/2326-6066.CIR-15-0215","volume":"4","author":"TD Prickett","year":"2016","unstructured":"Prickett TD, Crystal JS, Cohen CJ, Pasetto A, Parkhurst MR, Gartner JJ, Yao X, Wang R, Gros A, Li YF, et al. Durable complete response from Metastatic melanoma after transfer of Autologous T cells recognizing 10 mutated tumor antigens. Cancer Immunol Res. 2016;4:669\u201378.","journal-title":"Cancer Immunol Res"},{"key":"7619_CR8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1158\/0008-5472.CAN-19-0225","volume":"79","author":"V Zoete","year":"2019","unstructured":"Zoete V, Coukos G. Going beyond the sequences: TCR binding patterns at the service of cancer detection. Cancer Res. 2019;79:1299\u2013301.","journal-title":"Cancer Res"},{"key":"7619_CR9","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1158\/0008-5472.CAN-18-2292","volume":"79","author":"J Ostmeyer","year":"2019","unstructured":"Ostmeyer J, Christley S, Toby IT, Cowell LG. Biophysicochemical motifs in T-cell receptor sequences distinguish repertoires from tumor-infiltrating lymphocyte and adjacent healthy tissue. Cancer Res. 2019;79:1671\u201380.","journal-title":"Cancer Res"},{"key":"7619_CR10","doi-asserted-by":"publisher","first-page":"e81952","DOI":"10.7554\/eLife.81952","volume":"11","author":"M Pan","year":"2022","unstructured":"Pan M, Li B. T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies. eLife. 2022;11:e81952.","journal-title":"eLife"},{"key":"7619_CR11","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.3389\/fimmu.2019.02985","volume":"10","author":"TJ Looney","year":"2019","unstructured":"Looney TJ, Topacio-Hall D, Lowman G, Conroy J, Morrison C, Oh D, Fong L, Zhang L. TCR convergence in individuals treated with Immune checkpoint inhibition for cancer. Front Immunol. 2019;10:2985.","journal-title":"Front Immunol"},{"key":"7619_CR12","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/pcmr.12866","volume":"33","author":"J Charles","year":"2020","unstructured":"Charles J, Mouret S, Challende I, Leccia MT, De Fraipont F, Perez S, Plantier N, Plumas J, Manuel M, Chaperot L, Aspord C. T-cell receptor diversity as a prognostic biomarker in melanoma patients. Pigment Cell Melanoma Res. 2020;33:612\u201324.","journal-title":"Pigment Cell Melanoma Res"},{"key":"7619_CR13","doi-asserted-by":"publisher","first-page":"649343","DOI":"10.3389\/fimmu.2021.649343","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Wang J, Wu L, Li X, Zhang X, Zhang G, Xu S, Sun S, Jiao S. Diversity of dominant peripheral T cell receptor clone and soluble Immune checkpoint proteins associated with clinical outcomes following Immune checkpoint inhibitor treatment in Advanced Cancers. Front Immunol. 2021;12:649343.","journal-title":"Front Immunol"},{"key":"7619_CR14","doi-asserted-by":"publisher","first-page":"853403","DOI":"10.3389\/fimmu.2022.853403","volume":"13","author":"CM Chang","year":"2022","unstructured":"Chang CM, Peng KY, Chan CK, Lin YF, Liao HW, Chang JG, Wu MS, Wu VC, Chang WC. Divergent characteristics of T-Cell receptor repertoire between essential hypertension and aldosterone-producing adenoma. Front Immunol. 2022;13:853403.","journal-title":"Front Immunol"},{"key":"7619_CR15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00285-012-0589-7","volume":"67","author":"GA Rempala","year":"2013","unstructured":"Rempala GA, Seweryn M. Methods for diversity and overlap analysis in T-cell receptor populations. J Math Biol. 2013;67:1339\u201368.","journal-title":"J Math Biol"},{"key":"7619_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.copbio.2020.07.010","volume":"65","author":"J Chiffelle","year":"2020","unstructured":"Chiffelle J, Genolet R, Perez MA, Coukos G, Zoete V, Harari A. T-cell repertoire analysis and metrics of diversity and clonality. Curr Opin Biotechnol. 2020;65:284\u201395.","journal-title":"Curr Opin Biotechnol"},{"key":"7619_CR17","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/cancers14071771","volume":"14","author":"A Aran","year":"2022","unstructured":"Aran A, Garrigos L, Curigliano G, Cortes J, Marti M. Evaluation of the TCR repertoire as a predictive and prognostic biomarker in cancer: diversity or clonality? Cancers (Basel). 2022;14:1771.","journal-title":"Cancers (basel)"},{"key":"7619_CR18","doi-asserted-by":"publisher","first-page":"e1004503","DOI":"10.1371\/journal.pcbi.1004503","volume":"11","author":"M Shugay","year":"2015","unstructured":"Shugay M, Bagaev DV, Turchaninova MA, Bolotin DA, Britanova OV, Putintseva EV, Pogorelyy MV, Nazarov VI, Zvyagin IV, Kirgizova VI, et al. Vdjtools: unifying post-analysis of T cell receptor repertoires. PLoS Comput Biol. 2015;11:e1004503.","journal-title":"PLoS Comput Biol"},{"key":"7619_CR19","unstructured":"ImmunoMind T: immunarch:. An R Package for painless Bioinformatics analysis of T-Cell and B-Cell Immune repertoires. 2019."},{"key":"7619_CR20","first-page":"103439","volume":"72","author":"B Bardwell","year":"2024","unstructured":"Bardwell B, Bay J, Colburn Z. The clinical applications of immunosequencing. Curr Res Transl Med. 2024;72:103439.","journal-title":"Curr Res Transl Med"},{"key":"7619_CR21","first-page":"1251","volume-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","author":"KE Yost","year":"2019","unstructured":"Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA, et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Vol. 25. Nature Publishing Group; 2019. p. 1251\u201359."},{"key":"7619_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/intimm\/dxh194","volume":"17","author":"Y Iwai","year":"2005","unstructured":"Iwai Y, Terawaki S, Honjo T. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int Immunol. 2005;17:133\u201344.","journal-title":"Int Immunol"},{"key":"7619_CR23","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1158\/1078-0432.CCR-16-0664","volume":"23","author":"A Barone","year":"2017","unstructured":"Barone A, Hazarika M, Theoret MR, Mishra-Kalyani P, Chen H, He K, Sridhara R, Subramaniam S, Pfuma E, Wang Y, et al. FDA approval summary: pembrolizumab for the treatment of patients with unresectable or Metastatic melanoma. Clin Cancer Res. 2017;23:5661\u201365.","journal-title":"Clin Cancer Res"},{"key":"7619_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imr.12666","volume":"284","author":"BD Corrie","year":"2018","unstructured":"Corrie BD, Marthandan N, Zimonja B, Jaglale J, Zhou Y, Barr E, Knoetze N, Breden FMW, Christley S, Scott JK, et al. iReceptor: a platform for querying and analyzing antibody\/B-cell and T-cell receptor repertoire data across federated repositories. Immunol Rev. 2018;284:24\u201341.","journal-title":"Immunol Rev"},{"key":"7619_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fdata.2020.00022","volume":"3","author":"S Christley","year":"2020","unstructured":"Christley S, Aguiar A, Blanck G, Breden F, Bukhari SAC, Busse CE, Jaglale J, Harikrishnan SL, Laserson U, Peters B, et al. The ADC API: a web API for the programmatic query of the AIRR data Commons. Front Big Data. 2020;3:22.","journal-title":"Front Big Data"},{"key":"7619_CR26","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ni.3873","volume":"18","author":"F Rubelt","year":"2017","unstructured":"Rubelt F, Busse CE, Bukhari SAC, Burckert JP, Mariotti-Ferrandiz E, Cowell LG, Watson CT, Marthandan N, Faison WJ, Hershberg U, et al. Adaptive Immune receptor repertoire community recommendations for sharing immune-repertoire sequencing data. Nat Immunol. 2017;18:1274\u201378.","journal-title":"Nat Immunol"},{"key":"7619_CR27","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.3389\/fimmu.2018.02206","volume":"9","author":"JA Vander Heiden","year":"2018","unstructured":"Vander Heiden JA, Marquez S, Marthandan N, Bukhari SAC, Busse CE, Corrie B, Hershberg U, Kleinstein SH, Iv Fa M, Ralph DK, et al. AIRR community standardized representations for annotated Immune repertoires. Front Immunol. 2018;9:2206.","journal-title":"Front Immunol"},{"key":"7619_CR28","volume-title":"Immunodiversity assessment method and its use","author":"J Han","year":"2012","unstructured":"Han J. Immunodiversity assessment method and its use. (World Intellectual Property O ed.: Cb Biotechnologies, Inc.; 2012."},{"key":"7619_CR29","unstructured":"Gini C. Variabilit\u00e0 e mutabilit\u00e0: contributo allo studio delle distribuzioni e delle relazioni statistiche. [Fasc. I.]. Tipogr. di P. Cuppini; 1912."},{"key":"7619_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","volume":"27","author":"CE Shannon","year":"1948","unstructured":"Shannon CE. A mathematical theory of communication. Bell System Technical J. 1948;27:379\u2013423.","journal-title":"Bell System Technical J"},{"key":"7619_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/163688a0","volume":"163","author":"EH Simpson","year":"1949","unstructured":"Simpson EH. Measurement of diversity. Nature. 1949;163:688\u2013688.","journal-title":"Nature"},{"key":"7619_CR32","first-page":"265","volume":"11","author":"A Chao","year":"1984","unstructured":"Chao A. Nonparametric-estimation of the number of classes in a population. Scand J Stat. 1984;11:265\u201370.","journal-title":"Scand J Stat"},{"key":"7619_CR33","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1093\/nar\/18.20.6097","volume":"18","author":"TD Schneider","year":"1990","unstructured":"Schneider TD, Stephens RM. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 1990;18:6097\u2013100.","journal-title":"Nucleic Acids Res"},{"key":"7619_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1126\/science.8211163","volume":"262","author":"E Padovan","year":"1993","unstructured":"Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A. Expression of two T cell receptor alpha chains: dual receptor T cells. Science. 1993;262:422\u201324.","journal-title":"Science"},{"key":"7619_CR35","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1084\/jem.181.4.1391","volume":"181","author":"F Davodeau","year":"1995","unstructured":"Davodeau F, Peyrat MA, Romagne F, Necker A, Hallet MM, Vie H, Bonneville M. Dual T cell receptor beta chain expression on human T lymphocytes. J Exp Med. 1995;181:1391\u201398.","journal-title":"J Exp Med"},{"key":"7619_CR36","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1126\/science.abb9847","volume":"370","author":"S Krishna","year":"2020","unstructured":"Krishna S, Lowery FJ, Copeland AR, Bahadiroglu E, Mukherjee R, Jia L, Anibal JT, Sachs A, Adebola SO, Gurusamy D, et al. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science. 2020;370:1328\u201334.","journal-title":"Science"},{"key":"7619_CR37","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/2159-8290.CD-23-1334","volume":"14","author":"AJ Schoenfeld","year":"2024","unstructured":"Schoenfeld AJ, Lee SM, Doger de Speville B, Gettinger SN, Hafliger S, Sukari A, Papa S, Rodriguez-Moreno JF, Graf Finckenstein F, Fiaz R, et al. Lifileucel, an Autologous tumor-infiltrating lymphocyte Monotherapy, in patients with Advanced non-small cell Lung cancer resistant to Immune checkpoint inhibitors. Cancer Discov. 2024;14:1389\u2013402.","journal-title":"Cancer Discov"},{"key":"7619_CR38","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1158\/2159-8290.CD-24-0645","volume":"14","author":"MT Lotze","year":"2024","unstructured":"Lotze MT, Maeurer M, Quezada SA, Coukos G. Lung cancer adoptive cell therapy: inspiring til act comes center stage. Cancer Discov. 2024;14:1366\u201368.","journal-title":"Cancer Discov"},{"key":"7619_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.immuni.2018.03.009","volume":"48","author":"DI Godfrey","year":"2018","unstructured":"Godfrey DI, Le Nours J, Andrews DM, Uldrich AP, Rossjohn J. Unconventional T cell targets for cancer immunotherapy. Immunity. 2018;48:453\u201373.","journal-title":"Immunity"},{"key":"7619_CR40","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/2211-5463.12690","volume":"9","author":"K Yu","year":"2019","unstructured":"Yu K, Shi J, Lu D, Yang Q. Comparative analysis of CDR3 regions in paired human alphabeta CD8 T cells. FEBS Open Bio. 2019;9:1450\u201359.","journal-title":"FEBS Open Bio"},{"key":"7619_CR41","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1172\/JCI124358","volume":"129","author":"M Khosravi-Maharlooei","year":"2019","unstructured":"Khosravi-Maharlooei M, Obradovic A, Misra A, Motwani K, Holzl M, Seay HR, DeWolf S, Nauman G, Danzl N, Li H, et al. Crossreactive public TCR sequences undergo positive selection in the human thymic repertoire. J Clin Invest. 2019;129:2446\u201362.","journal-title":"J Clin Invest"},{"key":"7619_CR42","doi-asserted-by":"publisher","first-page":"113279","DOI":"10.1016\/j.celrep.2023.113279","volume":"42","author":"DG Chen","year":"2023","unstructured":"Chen DG, Xie J, Su Y, Heath JR. T cell receptor sequences are the dominant factor contributing to the phenotype of CD8(+) T cells with specificities against immunogenic viral antigens. Cell Rep. 2023;42:113279.","journal-title":"Cell Rep"},{"key":"7619_CR43","doi-asserted-by":"crossref","unstructured":"Drost F, Dorigatti E, Straub A, Hilgendorf P, Wagner KI, Heyer K, Lopez Montes M, Bischl B, Busch DH, Schober K, Schubert B. Predicting T cell receptor functionality against mutant epitopes. Cell Genom. 2024;100634.","DOI":"10.1016\/j.xgen.2024.100634"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07619-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07619-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07619-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:19:38Z","timestamp":1773145178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07619-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7619"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07619-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Champalimaud Foundation Ethics Committee (December 7th, 2021, CAN-TREAT) and was conducted in accordance with Good Clinical Practice guidelines. Dispensable tissue samples were obtained from the Champalimaud Foundation Biobank. Informed consent was obtained for study volunteers in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WP and MB-S are employees of iRepertoire. JH is the Founder and Chairman of the board of iRepertoire. The remaining authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}